TrademarkDir
CYTOTIL15
LIVE

Serial Number

90710889

Owner

Obsidian Therapeutics, Inc.

Attorney

Olivia Maria Baratta

First Use Date

Sep 30, 2022

Filing Date

May 14, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

CYTOTIL15 Trademark

Serial Number: 90710889 • Registration: 7995058

CYTOTIL15 is a trademark filed by Obsidian Therapeutics, Inc. on May 14, 2021. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Obsidian Therapeutics, Inc. (24 trademarks)

1030 Massachusetts Avenue, Fourth Floor
Cambridge, MA 02138

Entity Type: 03

Trademark Details

Filing Date

May 14, 2021

Registration Date

October 21, 2025

First Use Anywhere

September 30, 2022

First Use in Commerce

September 30, 2022

Published for Opposition

March 1, 2022

Goods & Services

Custom manufacture of cells for medical or clinical use for others; Custom manufacture of pharmaceutical preparations for others in the fields of cell therapy, gene therapy, regenerative medicine and biopharmaceuticals; Custom manufacture of biological preparations for others for the treatment of cancer

Medical and scientific research and development services in the fields of cell therapy, gene therapy, oncology, and immunotherapy

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 21, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 21, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 1, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 1, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 5, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 5, 2025 AITU
USE AMENDMENT FILED
Apr 17, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 17, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 24, 2024 EXRA
SOU EXTENSION 5 GRANTED
Oct 24, 2024 EX5G
SOU EXTENSION 5 FILED
Oct 24, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Oct 24, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 25, 2024 EXRA
SOU EXTENSION 4 GRANTED
Apr 24, 2024 EX4G
SOU EXTENSION 4 FILED
Apr 24, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 24, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 5, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jul 3, 2023 EX3G
SOU EXTENSION 3 FILED
Jul 3, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 3, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 5, 2023 EXRA
SOU EXTENSION 2 GRANTED
Apr 3, 2023 EX2G
SOU EXTENSION 2 FILED
Apr 3, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 3, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 28, 2022 EXRA
SOU EXTENSION 1 GRANTED
Oct 26, 2022 EX1G
SOU EXTENSION 1 FILED
Oct 26, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 26, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 26, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 1, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 1, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 9, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 25, 2022 CNSA
ASSIGNED TO EXAMINER
Jan 24, 2022 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 18, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 18, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 18, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 18, 2021 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 12, 2021 NWOS
NEW APPLICATION ENTERED
May 18, 2021 NWAP

Related Trademarks

More from this Owner

CYTOTIL15

CYTOTIL15

CYTOTIL15

CYTOTIL15

OBSIDIAN

OBSIDIAN

OBSIDIAN THERAPEUTICS

OBSIDIAN THERAPEUTICS

OBSIDIAN

OBSIDIAN

OBSIDIAN THERAPEUTICS

OBSIDIAN THERAPEUTICS